research Alopécie androgénogénétique chez la femme
Female pattern hair loss is common and increases with age.
Search
for
Sort by
Research
270-300 / 1000+ resultsresearch Alopecia areata incognito misdiagnosed as androgenetic alopecia- A Case Report
A woman was misdiagnosed with hair loss for years, but actually had a rare type of alopecia.
research P132 Quality of life, psychopathologic symptoms and personality disorders in subjects with androgenetic alopecia
Alopecia linked to higher anxiety and personality disorders.
research Telogen Effluvium
The debate focuses on the role of catagen and hair shedding mechanisms in telogen effluvium.
research Experience in the Treatment of Non-Scarring Alopecia Areata Using a Biomedical Cell Product Based on Autologous Follicular Stem Cells
Autologous follicular stem cells improved hair loss in 57% of patients.
research Trichodynia is a distinguishing symptom of telogen effluvium
Scalp pain is a common symptom in people with active hair loss from telogen effluvium.
research Clinicoepidemiological Observational Study of Acquired Alopecias in Females Correlating with Anemia and Thyroid Function
The study concluded that hair loss in Indian women is not significantly linked to anemia or thyroid problems, but checking thyroid function could help those with ongoing hair loss.
research Investigation of Hair Diseases Accompanying Bitemporal Alopecia: An Observational Cross‐Sectional Study
Bitemporal alopecia often occurs with other hair conditions and can help predict and monitor these issues.
research Prevalence of Non-Scarring Alopecia among Female Patients Complaining from Hirsutism
Androgenetic alopecia with telogen effluvium is the most common hair loss in women with hirsutism.
research Telogen effluvium
Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.
research DRUG‐ASSOCIATED ALOPECIA
Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.
research Follicular Density and Ratios in Scarring and Nonscarring Alopecia
Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.
research Telogen Effluvium: Is There a Need for a New Classification
The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.
research Telogen Effluvium
Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.
research Hair Shedding Evaluation for Alopecia: A Refined Wash Test
The refined wash test is a reliable way to measure daily hair loss and can tell the difference between different types of hair loss.
research Non-Scarring Alopecia in Women Presenting with Hair Loss: Clinical Features and Influencing Factors
Telogen effluvium is the most common hair loss in women, often linked to low iron, while tight hairstyles and headscarves increase traction alopecia risk.
research Real-World Quantification of Treatment Response to Low-Dose Oral Minoxidil in Non-Scarring Alopecia
Low-dose oral minoxidil significantly improves hair density in non-scarring alopecia.
research Trichoscopic Hallmarks in Non-cicatricial and Cicatricial Alopecia in Indian Population: A Narrative Review
Trichoscopy helps diagnose and manage different types of hair loss in the Indian population.
research Postpartum Telogen Effluvium Unmasking Additional Latent Hair Loss Disorders.
Postpartum hair loss can reveal hidden hair loss conditions.
research IMPACTOS CAPILARES DA COVID-19 A LIGAÇÃO ENTRE EFLÚVIO TELÓGENO AGUDO E ALOPECIA AREATA: REVISÃO INTEGRATIVA
Covid-19 can cause hair loss due to immune and psychological factors.
research Investigation of the comprehensive treatment’s clinical efficacy of various types of alopecia using proteoglycan replacement therapy
Proteoglycan replacement therapy improved hair conditions in most patients with alopecia.
research COVID-19-induced Scalp Alopecia Treated Effectively with Stem Cell Serum
Stem cell serum effectively treated hair loss caused by COVID-19.
research Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium
COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.
research Alopecia Areata: Why is it Areata?
The paper concludes that the patchiness of alopecia areata is likely due to when the immune attack happens in the hair growth cycle.
research Approach to the adult female patient with diffuse nonscarring alopecia
The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.
research Acquired scalp alopecia. Part I: A review
Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.
research ‘Black dots’ seen under trichoscopy are not specific for alopecia areata
Black dots under trichoscopy can appear in different hair and scalp conditions, not just in alopecia areata.
research Destruction of the arrector pili muscle and fat infiltration in androgenic alopecia
Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.
research Telogen Effluvium
Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.
research Telogen Alopecia From UV Rays
UV rays can cause a type of hair loss known as telogen alopecia.